Neuronity Therapeutics

Biotech company developing Fist-in-Class gene therapy for Parkinson's disease

[Neuronity Therapeutics @NeuronityTX]

Are your microglia getting smarter in the aging brain? @NeuronityTX is developing therapeutics to keep your microglia healthy. Check out our website https://t.co/ybby0AllnO.
#Parkinson
#microglia

[Neuronity Therapeutics @NeuronityTX]

https://t.co/TfTYu3GnC5

[Parkinson's News Today @parkinsonstory]

Is there one particular symptom that affects your life the most? Share it with us in our forums. https://t.co/4Ztg2cEOOE

#parkinsonssymptoms #parkinsonsdiseaseresearch #parkinsonsdisease #livingwithparkinsons #parkinsonsforums

[Neuronity Therapeutics @NeuronityTX]

Great updates for studies on how to define #Parkinson and track the progression!

[MDS @movedisorder]

2 papers from PPMI with different meanings for Day 1 of Aspen:

1. https://t.co/PrJMdMXRCO - a +αSyn-SAA defines Parkinson's "biologically." No correlation with disease severity of progression.

2. https://t.co/ZEvkdhY9Yb - lower CSF αSyn predicts progression.

@AlbertoEspay

[Neuronity Therapeutics @NeuronityTX]

https://t.co/h4QXCRmKcx

[Neuronity Therapeutics @NeuronityTX]

We are pleased to share the news that Neuronity received grant funding in collaboration with @universityofga from @MichaelJFoxOrg.

https://t.co/FuH3FDO3Kr

[Greg Dunn Neuro Art @GDunnArt]

That's what corticothalamic feedback in the brain looks like, friend! A gyrus from the parietal cortex making the synthesis of movement and motion possible.
⁠https://t.co/GWrfmQDz59⁠
⁠#brain #neuro #neurology #psychiatry #mentalhealth #psychedelic #neurosurgery #sciart

[The Innovation Space @DE_Innovates]

We're excited to welcome the next cohort of Science Inc.™, our virtual accelerator for #ScienceStartups:
@AllyPowerInc
Ardan Pharma
Atlas FermenTech
@GoFlowMedical
@NeuronityTX
NKILT Therapeutics
Novaurum Biosciences
OncoXome
Quantum Copper
Score Pharma

https://t.co/aM4t8xpFD2

[Neuronity Therapeutics @NeuronityTX]

Neuronity is attending Fierce Biotech Summit in Boston! https://t.co/uWixxDxlrU

[Neuronity Therapeutics @NeuronityTX]

Neuronity is honored to join Science Inc. accelerator program. We appreciate the Innovation space for this amazing opportunity.

[The Innovation Space @DE_Innovates]

We are thrilled to welcome ten new companies to our Fall 2022 Science Inc.™ virtual accelerator for early-stage science-based startups. This cohort includes companies specializing in cell and gene therapy, medical technology, and clean energy. https://t.co/PTzs2OKzRQ

[Prof Jane Alty @janealty1]

🖐 A new #contactless method for measuring #Parkinsons hand #bradykinesia. Congrats to superstar PhD student Stefan Williams and all the team 👏. https://t.co/QqsRSahv9I

[Neuronity Therapeutics @NeuronityTX]

https://t.co/1Vmzy8Eon7

[Science Translational Medicine @ScienceTM]

New experiments from Langston, @MarkRCookson1, and colleagues reveal that #microglia may explain how noncoding mutations in #LRRK2 raise the risk of #ParkinsonsDisease, despite expressing the gene less than other cell types. @NIHAging @SingletonNeuro https://t.co/AQzXlOSAOL

[Alino Martinez-Marcos @AlinoMartinez]

microglia embracing Lewy body in the brain of a patient suffering from Parkinson's disease

[Dr. Kaouthar Lbiati @kaoutharlbiati]

“#CRISPR Technology for DNA Editing Might Raise Cancer Risk” Israeli study (published). The U.S. Food and Drug Administration is expected to approve the first CRISPR treatments next year #geneediting #aneuploidy #intellia #FDA ⁦@yaireinhorn⁩ https://t.co/CsYc7xanTg.

[IAPRD @PRDAssociation]

What really causes Parkinson’s disease?
A. Inflammation
B. Mitochondrial dysfunction
C. Synucleinopathy
D. Lysosomal dysfunction.
Weigh the evidence presented #IAPRD2019 in Montreal, Canada, 16-19 June 2019 in our session on basic disease mechanisms.
https://t.co/ZcMCu7ACGj

[Alzforum @alzforum]

For the first time, a PET tracer detects α-synuclein aggregates in the brains of people with a synucleinopathy. https://t.co/ydpISlee6T

[Ray Dorsey, MD @RayDorseyMD]

Parkinson's Disease is the world's fastest growing neurological disorder, affecting 6 million people around the world. We can stop it. Preorder now at https://t.co/jQG4u7sYho - Coming March 17.
@basbloem @MichaelOkun #ToddSherer
#health #Parkinsons #book #endingPD

[Science Magazine @ScienceMagazine]

Rhythmic fluid flows in deep sleep may allow communication and clearance of waste products in the brain, according to Science research from 2019.

Learn more: https://t.co/VGJttvdpN9

[Parkinson's Humor 😜 🇺🇲 @YumaBev]

When you have a #Parkinsons tremor in your dominant hand, eating small foods like peas can be a struggle.
https://t.co/yr4QyWJzZf
Use mashed potatoes as glue and
Have a Happy Parky Day!